Clinical Trials

166 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04500717 2020-08-05

ACROSS2

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02004184 2020-06-23

IDA

230 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

70 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT02900742 2019-04-12

Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer

71 enrolled

Lung Neoplasms, Neoplasms

NCT02162537 2019-02-01

METAL2

95 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01041781 2018-07-23

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

313 enrolled 14 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01631136 2018-01-17

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

932 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03061058 2017-09-15

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

240 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03269162 2017-09-14

Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection

144 enrolled

NSCLC

NCT03193788 2017-06-21

PREMIER

74 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT00863512 2017-03-27

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

34 enrolled 6 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02859077 2016-08-09

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00976456 2016-03-10

65plus

271 enrolled 8 charts

Lung Neoplasms

NCT02518802 2015-08-10

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

220 enrolled

Lung Neoplasms

NCT01282151 2015-07-14

TRAIL

148 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

392 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00005636 2013-06-19

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00440414 2010-08-19

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

320 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01066195 2010-02-10

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

129 enrolled